...
search icon
dcth-img

Delcath Systems Inc Share Price

DCTH
NAQ
$9.31
+$0.19
(2.08%)
1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Delcath Systems Inc Analyst Forecast

Delcath Systems Inc Share Price Chart

Delcath Systems Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$316.46M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
304
Volume info-icon
This is the total number of shares traded during the most recent trading day.
296.33K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.36
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$8.12 L
$18.23 H
$9.31

About Delcath Systems Inc, Common Stock

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1987 and is headquartered in New York, New York. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Delcath Systems Inc Stock Returns

Time FrameDCTHSectorS&P500
1-Week Return-0.64%-1.08%-1.38%
1-Month Return-10.65%-0.47%-1.81%
3-Month Return8.13%2.13%1.38%
6-Month Return-16.2%17.04%5.68%
1-Year Return-42.81%6.56%11.74%
3-Year Return89.23%16.78%65.15%
5-Year Return-60.65%34.34%73.68%
10-Year Return3225%137.88%260.03%

Delcath Systems Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue1.65M3.56M2.72M2.06M37.20M[{"date":"2020-12-31","value":4.42,"profit":true},{"date":"2021-12-31","value":9.56,"profit":true},{"date":"2022-12-31","value":7.31,"profit":true},{"date":"2023-12-31","value":5.55,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue640.00K671.00K686.00K635.00K6.19M[{"date":"2020-12-31","value":10.34,"profit":true},{"date":"2021-12-31","value":10.84,"profit":true},{"date":"2022-12-31","value":11.09,"profit":true},{"date":"2023-12-31","value":10.26,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit1.01M2.88M2.03M1.43M31.02M[{"date":"2020-12-31","value":3.24,"profit":true},{"date":"2021-12-31","value":9.3,"profit":true},{"date":"2022-12-31","value":6.55,"profit":true},{"date":"2023-12-31","value":4.61,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin61.12%81.13%74.77%69.25%83.37%[{"date":"2020-12-31","value":73.31,"profit":true},{"date":"2021-12-31","value":97.31,"profit":true},{"date":"2022-12-31","value":89.69,"profit":true},{"date":"2023-12-31","value":83.06,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses22.31M27.41M35.89M39.61M43.43M[{"date":"2020-12-31","value":51.37,"profit":true},{"date":"2021-12-31","value":63.13,"profit":true},{"date":"2022-12-31","value":82.64,"profit":true},{"date":"2023-12-31","value":91.22,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(21.30M)(24.53M)(33.85M)(38.18M)(12.41M)[{"date":"2020-12-31","value":-2130300000,"profit":false},{"date":"2021-12-31","value":-2453100000,"profit":false},{"date":"2022-12-31","value":-3385300000,"profit":false},{"date":"2023-12-31","value":-3818200000,"profit":false},{"date":"2024-12-31","value":-1241000000,"profit":false}]
Total Non-Operating Income/Expense(3.03M)(2.30M)(5.34M)(11.60M)(13.85M)[{"date":"2020-12-31","value":-302800000,"profit":false},{"date":"2021-12-31","value":-230400000,"profit":false},{"date":"2022-12-31","value":-534000000,"profit":false},{"date":"2023-12-31","value":-1159500000,"profit":false},{"date":"2024-12-31","value":-1385100000,"profit":false}]
Pre-Tax Income(24.16M)(25.65M)(36.51M)(47.68M)(26.39M)[{"date":"2020-12-31","value":-2415600000,"profit":false},{"date":"2021-12-31","value":-2564900000,"profit":false},{"date":"2022-12-31","value":-3650800000,"profit":false},{"date":"2023-12-31","value":-4767800000,"profit":false},{"date":"2024-12-31","value":-2638600000,"profit":false}]
Income Taxes329.00K1.11M2.65M(39.90K)-[{"date":"2020-12-31","value":12.39,"profit":true},{"date":"2021-12-31","value":41.73,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.5,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(24.48M)(26.76M)(39.16M)(47.64M)-[{"date":"2020-12-31","value":-2448500000,"profit":false},{"date":"2021-12-31","value":-2675700000,"profit":false},{"date":"2022-12-31","value":-3916300000,"profit":false},{"date":"2023-12-31","value":-4763810500,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(24.16M)(25.65M)(36.51M)(45.01M)(26.39M)[{"date":"2020-12-31","value":-2415600000,"profit":false},{"date":"2021-12-31","value":-2564900000,"profit":false},{"date":"2022-12-31","value":-3650800000,"profit":false},{"date":"2023-12-31","value":-4501400000,"profit":false},{"date":"2024-12-31","value":-2638600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(24.16M)(25.65M)(36.51M)(47.68M)(26.39M)[{"date":"2020-12-31","value":-2415600000,"profit":false},{"date":"2021-12-31","value":-2564900000,"profit":false},{"date":"2022-12-31","value":-3650800000,"profit":false},{"date":"2023-12-31","value":-4767800000,"profit":false},{"date":"2024-12-31","value":-2638600000,"profit":false}]
EPS (Diluted)(111.73)(3.63)(4.12)(3.06)(0.98)[{"date":"2020-12-31","value":-11173,"profit":false},{"date":"2021-12-31","value":-363,"profit":false},{"date":"2022-12-31","value":-412,"profit":false},{"date":"2023-12-31","value":-306,"profit":false},{"date":"2024-12-31","value":-98,"profit":false}]

Delcath Systems Inc Ratios

Delcath Systems Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

DCTH
Cash Ratio 11.10
Current Ratio 15.06
Quick Ratio 13.71

Delcath Systems Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DCTH
ROA (LTM) 4.72%
ROE (LTM) 1.94%

Delcath Systems Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DCTH
Debt Ratio Lower is generally better. Negative is bad. 0.08
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.92

Delcath Systems Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DCTH
Trailing PE 304.00
Forward PE 26.45
P/S (TTM) 4.05
P/B 2.76
Price/FCF 75
EV/R 2.87
EV/Ebitda 36.91

FAQs

What is Delcath Systems Inc share price today?

Delcath Systems Inc (DCTH) share price today is $9.31

Can Indians buy Delcath Systems Inc shares?

Yes, Indians can buy shares of Delcath Systems Inc (DCTH) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DCTH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Delcath Systems Inc be purchased?

Yes, you can purchase fractional shares of Delcath Systems Inc (DCTH) via the Vested app. You can start investing in Delcath Systems Inc (DCTH) with a minimum investment of $1.

How to invest in Delcath Systems Inc shares from India?

You can invest in shares of Delcath Systems Inc (DCTH) via Vested in three simple steps:

  • Click on Sign Up or Invest in DCTH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Delcath Systems Inc shares
What is Delcath Systems Inc 52-week high and low stock price?

The 52-week high price of Delcath Systems Inc (DCTH) is $18.23. The 52-week low price of Delcath Systems Inc (DCTH) is $8.12.

What is Delcath Systems Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Delcath Systems Inc (DCTH) is 304

What is Delcath Systems Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Delcath Systems Inc (DCTH) is 2.76

What is Delcath Systems Inc dividend yield?

The dividend yield of Delcath Systems Inc (DCTH) is 0.00%

What is the Market Cap of Delcath Systems Inc?

The market capitalization of Delcath Systems Inc (DCTH) is $316.46M

What is Delcath Systems Inc's stock symbol?

The stock symbol (or ticker) of Delcath Systems Inc is DCTH

How Can Investors Use Delcath Systems Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Delcath Systems Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Delcath Systems Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Delcath Systems Inc shares for Indian investors?

When investing in Delcath Systems Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Delcath Systems Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Delcath Systems Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Delcath Systems Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Delcath Systems Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top